AChE antibodies have been reported in 5–50% of MG patients, but they are not specific for MG since they are also found in many patients with other autoimmune diseases, while no correlation has been identified with clinical characteristics or symptoms (62–64). Here, ACHE is linked to myasthenia gravis.